Reperio Health
Unknown, US · Founded 2020 · Delaware corporation · 2 known investors
Reperio Health builds diagnostic tools and automated systems powered by AI/ML for enterprise deployment, with infrastructure for real-time data processing. The company serves large enterprises across technology and other sectors.
Founders & leadership
D
Dustinin
TR
Travis RushExecutive Officer, Director
MW
Matthew WallingtonExecutive Officer, Director
JA
JUSTIN AUTREYHEAD OF SUPPLY CHAIN
EC
ELIZABETH CURTISCHIEF OF STAFF
TA
TORY ADAMSSENIOR SOFTWARE ENGINEER
CJ
CHARLES JEWELLVICE PRESIDENT ENGINEERING
IC
ILDIKO CRISTCHIEF MARKETING OFFICER
PH
Philip HertikDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$5.1MraisedDec 2024 · 14 investors · Other TechnologyRule 506(b)
▶$5.1MraisedDec 2024 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WallingtonExecutive Officer, Director
- Philip HertikDirector
- Travis RushExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $5.1M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.6MraisedApr 2024 · 9 investors · Other Health CareRule 506(b)
▶$1.6MraisedApr 2024 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- TRAVIS RUSHExecutive Officer, Director
- PHILIP HERTIKDirector
- MATTHEW WALLINGTONExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.6M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$500KraisedNov 2023 · 1 investors · Other TechnologyRule 506(b)
▶$500KraisedNov 2023 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WallingtonExecutive Officer, Director
- Philip HertikDirector
- Travis RushExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $500K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8.2MraisedSep 2023 · 40 investors · Other Health CareRule 506(b)
▶$8.2MraisedSep 2023 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- TRAVIS RUSHExecutive Officer, Director
- MATTHEW WALLINGTONExecutive Officer, Director
- PHILIP HERTIKDirector
- Offering amount
- $8.2M
- Amount sold
- $8.2M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedMay 2023 · 2 investors · Other Health CareRule 506(b)
▶$2MraisedMay 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- MATTHEW WALLINGTONExecutive Officer, Director
- TRAVIS RUSHExecutive Officer, Director
- PHILIP HERTIKDirector
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6MraisedMar 2021 · 18 investors · Other Health CareRule 506(b)
▶$6MraisedMar 2021 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JUSTIN AUTREYExecutive Officer
- ELIZABETH CURTISExecutive Officer
- Philip HertikDirector
- TORY ADAMSExecutive Officer
- CHARLES JEWELLExecutive Officer
- MATTHEW WALLINGTONExecutive Officer, Director
- ILDIKO CRISTExecutive Officer
- TRAVIS RUSHExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $6M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.